2.50
Hdl Handle:
http://hdl.handle.net/10541/70314
Title:
Management of oral mucositis at European transplantation centres
Authors:
Stone, Rebecca; Potting, Carin M J; Clare, Simon; Uhlenhopp, Mary; Davies, Michelle; Mank, Arno P; Quinn, Barry
Abstract:
Oral mucositis (OM), which occurs in many patients with hematologic malignancies treated with high-dose therapy and stem cell transplantation, is associated with substantial clinical, economic, and quality-of-life (QOL) consequences. It has been associated with an increased need for total parenteral nutrition and opioid analgesics, prolonged hospital stays, and increased risk of infection. The research subgroup of the European Group for Blood and Marrow Transplantation Nurses Group surveyed nurses at transplantation centres for their thoughts about the clinical, QOL, and economic consequences of OM; tools for assessing OM; strategies for preventing and treating OM; and the need for the development and implementation of treatment guidelines. The responses from 46 centres, in 16 countries, indicated that most nurses (91%) believe OM has a large effect on patients' QOL. Nurses are not highly satisfied with current treatments for OM, but they believe the discomfort is reduced with oral care protocols and mouthwashes. Oral mucositis is routinely and frequently assessed, however there are inconsistencies in how it is managed. Most centres used unpublished, centre-specific guidelines, and the survey found that most nurses agreed that published national guidelines would be valuable for standardising the assessment and management of OM.
Affiliation:
Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, City Campus, Hucknall Road, Nottingham NG5 1PB, UK. rebecca.stone@nuh.nhs.uk
Citation:
Management of oral mucositis at European transplantation centres. 2007, 11 Suppl 1:S3-9 Eur J Oncol Nurs
Journal:
European Journal of Oncology Nursing
Issue Date:
2007
URI:
http://hdl.handle.net/10541/70314
DOI:
10.1016/S1462-3889(07)70002-9
PubMed ID:
17540296
Type:
Article
Language:
en
ISSN:
1462-3889
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorStone, Rebecca-
dc.contributor.authorPotting, Carin M J-
dc.contributor.authorClare, Simon-
dc.contributor.authorUhlenhopp, Mary-
dc.contributor.authorDavies, Michelle-
dc.contributor.authorMank, Arno P-
dc.contributor.authorQuinn, Barry-
dc.date.accessioned2009-06-12T11:53:39Z-
dc.date.available2009-06-12T11:53:39Z-
dc.date.issued2007-
dc.identifier.citationManagement of oral mucositis at European transplantation centres. 2007, 11 Suppl 1:S3-9 Eur J Oncol Nursen
dc.identifier.issn1462-3889-
dc.identifier.pmid17540296-
dc.identifier.doi10.1016/S1462-3889(07)70002-9-
dc.identifier.urihttp://hdl.handle.net/10541/70314-
dc.description.abstractOral mucositis (OM), which occurs in many patients with hematologic malignancies treated with high-dose therapy and stem cell transplantation, is associated with substantial clinical, economic, and quality-of-life (QOL) consequences. It has been associated with an increased need for total parenteral nutrition and opioid analgesics, prolonged hospital stays, and increased risk of infection. The research subgroup of the European Group for Blood and Marrow Transplantation Nurses Group surveyed nurses at transplantation centres for their thoughts about the clinical, QOL, and economic consequences of OM; tools for assessing OM; strategies for preventing and treating OM; and the need for the development and implementation of treatment guidelines. The responses from 46 centres, in 16 countries, indicated that most nurses (91%) believe OM has a large effect on patients' QOL. Nurses are not highly satisfied with current treatments for OM, but they believe the discomfort is reduced with oral care protocols and mouthwashes. Oral mucositis is routinely and frequently assessed, however there are inconsistencies in how it is managed. Most centres used unpublished, centre-specific guidelines, and the survey found that most nurses agreed that published national guidelines would be valuable for standardising the assessment and management of OM.en
dc.language.isoenen
dc.subjectHematologic Canceren
dc.subject.meshEurope-
dc.subject.meshFibroblast Growth Factor 7-
dc.subject.meshHematologic Neoplasms-
dc.subject.meshHematopoietic Stem Cell Transplantation-
dc.subject.meshHumans-
dc.subject.meshMucositis-
dc.subject.meshNursing Assessment-
dc.subject.meshPractice Guidelines as Topic-
dc.subject.meshQuality of Life-
dc.subject.meshQuestionnaires-
dc.subject.meshTreatment Outcome-
dc.titleManagement of oral mucositis at European transplantation centresen
dc.typeArticleen
dc.contributor.departmentCentre for Clinical Haematology, Nottingham University Hospitals NHS Trust, City Campus, Hucknall Road, Nottingham NG5 1PB, UK. rebecca.stone@nuh.nhs.uken
dc.identifier.journalEuropean Journal of Oncology Nursingen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.